These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27417794)

  • 21. Left ventricular assist device-associated infections: incidence and risk factors.
    Rahal A; Ruch Y; Meyer N; Perrier S; Minh TH; Schneider C; Lavigne T; Marguerite S; Ajob G; Cristinar M; Epailly E; Mazzucotelli JP; Kindo M
    J Thorac Dis; 2020 May; 12(5):2654-2662. PubMed ID: 32642173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
    Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
    Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.
    Imamura T; Kinugawa K; Nitta D; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Ono M
    J Artif Organs; 2015 Jun; 18(2):120-7. PubMed ID: 25604148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome.
    Kim J; Feller ED; Chen W; Liang Y; Dilsizian V
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):722-729. PubMed ID: 29550312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
    Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices.
    Tsiouris A; Paone G; Nemeh HW; Borgi J; Williams CT; Lanfear DE; Morgan JA
    World J Cardiol; 2015 Nov; 7(11):792-800. PubMed ID: 26635927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium abscessus Infection in Left Ventricular Assist Device (LVAD): A Case Series.
    Hernandez JM; Huff M; Nlandu Z; Vekariya B; Torres J
    Cureus; 2021 Jun; 13(6):e15718. PubMed ID: 34290918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk analysis of bloodstream infection during long-term left ventricular assist device support.
    Toda K; Yonemoto Y; Fujita T; Shimahara Y; Sato S; Nakatani T; Kobayashi J
    Ann Thorac Surg; 2012 Nov; 94(5):1387-93. PubMed ID: 22571882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocarditis in left ventricular assist device.
    Thyagarajan B; Kumar MP; Sikachi RR; Agrawal A
    Intractable Rare Dis Res; 2016 Aug; 5(3):177-84. PubMed ID: 27672540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.
    Siegenthaler MP; Martin J; Pernice K; Doenst T; Sorg S; Trummer G; Friesewinkel O; Beyersdorf F
    Eur J Cardiothorac Surg; 2003 May; 23(5):748-54; discussion 754-5. PubMed ID: 12754028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
    Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
    J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Left Ventricular Assist Devices.
    Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
    Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection.
    Avramovic N; Dell'Aquila AM; Weckesser M; Milankovic D; Vrachimis A; Sindermann JR; Wenning C
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1870-1877. PubMed ID: 28547176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection.
    Poston RS; Husain S; Sorce D; Stanford E; Kusne S; Wagener M; Griffith BP; Kormos RL
    J Heart Lung Transplant; 2003 Aug; 22(8):914-21. PubMed ID: 12909473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.
    Hanff TC; Birati EY
    Curr Heart Fail Rep; 2019 Oct; 16(5):168-179. PubMed ID: 31631240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bridge to bridge surgery;conversion from extracorporeal left ventricular assist device to implantable left ventricular assist device].
    Kinoshita O; Ono M
    Kyobu Geka; 2013 Jul; 66(8 Suppl):690-5. PubMed ID: 23917187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management and Outcome of Left Ventricular Assist Device Infections in Patients Undergoing Cardiac Transplantation.
    Esquer Garrigos Z; Castillo Almeida NE; Gurram P; Vijayvargiya P; Corsini Campioli CG; Stulak JM; Rizza SA; Baddour LM; Rizwan Sohail M
    Open Forum Infect Dis; 2020 Aug; 7(8):ofaa303. PubMed ID: 32818144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with dalbavancin for long-term antimicrobial suppression of left ventricular assist device infections.
    Mansoor AE; Krekel T; Cabrera NL
    Transpl Infect Dis; 2023 Aug; 25(4):e14068. PubMed ID: 37159539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.